CAS: 1258417-54-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | ACT-389949 REF: TM-T10242CAS: 1258417-54-7 | 99.40% | 93,00 €~813,00 € | Mar 10 Dic 24 |
 | N-(2-((4-(1,1-Difluoroethyl)oxazol-2-yl)methyl)-2H-1,2,3-triazol-4-yl)-2-methyl-5-(m-tolyl)oxazole-4-carboxamide REF: IN-DA01N18BCAS: 1258417-54-7 | 99% | A consultar | Mar 10 Dic 24 |
 | ACT-389949 REF: 3D-IAC41754CAS: 1258417-54-7 | Min. 95% | A consultar | Mar 21 Ene 25 |
ACT-389949
CAS:1258417-54-7
ACT-389949: Potent, selective FPR2/ALX agonist; EC50 3 nM; potential inflammatory disorder treatment.
Fórmula:
C20H18F2N6O3
Pureza:
99.40%
Forma y color:
Solid
Peso molecular:
428.39
Ref: TM-T10242
| 1mg | 93,00 € | ||
| 5mg | 140,00 € | ||
| 10mg | 207,00 € | ||
| 25mg | 364,00 € | ||
| 50mg | 542,00 € | ||
| 100mg | 813,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
N-(2-((4-(1,1-Difluoroethyl)oxazol-2-yl)methyl)-2H-1,2,3-triazol-4-yl)-2-methyl-5-(m-tolyl)oxazole-4-carboxamide
CAS:1258417-54-7
Fórmula:
C20H18F2N6O3
Pureza:
99%
Forma y color:
Solid
Peso molecular:
428.3921
Ref: IN-DA01N18B
| 1mg | 149,00 € | ||
| 5mg | 297,00 € | ||
| 10mg | 589,00 € | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
ACT-389949
CAS:1258417-54-7
ACT-389949 is a novel small molecule that has been shown to be a potent inhibitor …
Fórmula:
C20H18F2N6O3
Pureza:
Min. 95%
Peso molecular:
428.4 g/mol
Ref: 3D-IAC41754
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
